

Experimental biologist with extensive postdoctoral research experience in cancer biology, biomarkers and metabolic diseases. Strong foundation in translational research, molecular biology and cell signaling. Strong publication record in high-impact peer reviewed journals (Citations- 946; h-index-14; i10 index-18). Reviewer in 7 peer reviewed journals with experience in teaching undergrad and master students. Adept at driving impactful projects, fostering collaborations and adaptable to evolving research needs.
Specific research projects
(*These authors contributed equally to this work)
2021–2025
- Insulin resistance and Metabolic dysfunction-associated steatohepatitis.
- Aging induced liver fibrosis
2016-2021
- Novel pathways in the pathogenesis and pathophysiology of HCC
- Pathway specific functional biomarkers for the early detection of liver cancer c
- Studies to determine the role of β2SP and Smad3 in the DNA damage response.
- Genomic analyses of Hepatocellular Carcinoma (HCC) samples and HCC mouse models to identify and validate the effects of the changes in the TGF-β pathway in HCC and identify potential therapeutic targets.
- Cross talk between Sirtuins and TGF-β signaling in liver steatosis and proliferation
2010 – 2016
- Role of Extra N-terminal Residues (-4 & -3) in the Folding and Stability of the Yeast Cytochrome- c.